Header Logo

Gregory Braden

Concepts (372)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Renal Dialysis
12
2019
161
1.830
Why?
Catheters, Indwelling
3
2015
55
1.210
Why?
Nephrologists
2
2020
4
1.030
Why?
Nephrology
2
2020
12
1.030
Why?
Catheter-Related Infections
4
2019
33
0.980
Why?
Fellowships and Scholarships
2
2020
60
0.980
Why?
Anti-Glomerular Basement Membrane Disease
1
2021
4
0.900
Why?
Glomerulonephritis
1
2021
21
0.890
Why?
Advisory Committees
1
2020
64
0.830
Why?
Kidney Transplantation
6
2012
153
0.830
Why?
Vascular Access Devices
2
2019
11
0.790
Why?
Societies, Medical
1
2020
211
0.760
Why?
Acidosis, Renal Tubular
1
2017
3
0.710
Why?
Melanoma
1
2021
273
0.710
Why?
Human Growth Hormone
1
2017
41
0.690
Why?
Growth Disorders
1
2017
47
0.690
Why?
Body Height
1
2017
101
0.680
Why?
Gentamicins
2
2014
21
0.670
Why?
Kidney
8
2013
329
0.620
Why?
Kidney Failure, Chronic
6
2019
141
0.610
Why?
Gastric Bypass
2
2013
64
0.600
Why?
Silicones
1
2015
12
0.600
Why?
Anti-Infective Agents, Local
1
2015
28
0.580
Why?
Anti-Bacterial Agents
4
2015
569
0.580
Why?
Diuretics
3
2011
51
0.570
Why?
Citrates
1
2014
15
0.560
Why?
Central Venous Catheters
1
2014
13
0.550
Why?
Calcium Oxalate
2
2013
9
0.530
Why?
Catheterization, Central Venous
1
2014
79
0.520
Why?
Hepatitis B Antibodies
1
2012
7
0.510
Why?
Acute Kidney Injury
3
2017
92
0.510
Why?
Hepatitis B Vaccines
1
2012
12
0.510
Why?
Hepatitis B Surface Antigens
1
2012
16
0.510
Why?
Living Donors
1
2012
37
0.500
Why?
Ethanol
1
2015
227
0.490
Why?
Obesity, Morbid
1
2013
76
0.480
Why?
Adaptive Immunity
1
2012
89
0.460
Why?
Purpura, Thrombocytopenic
1
2011
5
0.450
Why?
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
1
2011
19
0.450
Why?
Humans
59
2021
47750
0.450
Why?
Nephritis, Interstitial
3
2005
13
0.430
Why?
Male
31
2021
22954
0.420
Why?
Heart Failure
2
2017
647
0.400
Why?
Middle Aged
24
2021
13393
0.390
Why?
Personnel Selection
2
2020
40
0.370
Why?
Terbutaline
2
1998
4
0.360
Why?
Arteriovenous Shunt, Surgical
4
2019
37
0.360
Why?
Sarcoidosis
2
2005
20
0.340
Why?
Potassium
5
2011
88
0.330
Why?
Creatinine
6
2017
107
0.330
Why?
Hyperkalemia
2
2004
16
0.290
Why?
Immunosorbent Techniques
1
2004
10
0.290
Why?
Hemolytic-Uremic Syndrome
1
2004
9
0.290
Why?
Mitomycin
1
2004
17
0.290
Why?
Staphylococcal Protein A
1
2004
5
0.290
Why?
Antigen-Antibody Complex
1
2004
47
0.280
Why?
Antibiotics, Antineoplastic
1
2004
27
0.280
Why?
Peritoneal Dialysis
3
2011
12
0.270
Why?
Duodenitis
1
2003
2
0.270
Why?
Female
29
2017
25942
0.270
Why?
Cyclooxygenase Inhibitors
1
2004
32
0.270
Why?
Mycophenolic Acid
1
2003
27
0.270
Why?
Platelet Aggregation Inhibitors
3
2011
214
0.260
Why?
Kidney Diseases
5
2011
125
0.260
Why?
Pancreatitis
1
2003
81
0.260
Why?
Electrolytes
3
1998
30
0.240
Why?
Anti-Infective Agents
2
2019
102
0.240
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2003
172
0.240
Why?
Salaries and Fringe Benefits
1
2020
27
0.210
Why?
Kidney Glomerulus
1
2000
14
0.210
Why?
Autoantibodies
1
2021
150
0.210
Why?
Glomerular Filtration Rate
3
2011
71
0.210
Why?
Efficiency
1
2020
41
0.210
Why?
Acidosis
2
1993
20
0.210
Why?
Lupus Nephritis
1
2000
27
0.200
Why?
Mitogen-Activated Protein Kinases
1
2021
192
0.200
Why?
Treatment Outcome
6
2017
3762
0.200
Why?
Neoplasm Recurrence, Local
1
2021
229
0.200
Why?
Tissue Donors
1
2000
123
0.190
Why?
Infant, Premature
4
2007
150
0.190
Why?
Hand Disinfection
1
2019
14
0.190
Why?
Immunosuppressive Agents
3
2011
225
0.190
Why?
Aspirin
2
2011
175
0.190
Why?
Adrenergic beta-Agonists
1
1998
21
0.190
Why?
Osteopontin
2
2009
19
0.180
Why?
Graft Occlusion, Vascular
2
2009
67
0.180
Why?
Thrombosis
3
2011
185
0.180
Why?
Myocardial Contraction
1
1998
77
0.180
Why?
Faculty, Medical
1
2020
178
0.180
Why?
Oxalates
3
1997
15
0.180
Why?
Job Application
1
2017
4
0.180
Why?
Adult
17
2013
13043
0.170
Why?
Ritodrine
1
1997
1
0.170
Why?
Hypokalemia
1
1997
10
0.170
Why?
Risk Factors
7
2017
4158
0.170
Why?
Hemodynamics
1
1998
179
0.170
Why?
Obstetric Labor, Premature
1
1997
29
0.170
Why?
Proteinuria
3
2005
29
0.170
Why?
Heparin
2
2015
106
0.170
Why?
Time Factors
5
2017
3166
0.150
Why?
Allopurinol
2
2001
19
0.150
Why?
Vascular Patency
3
2011
130
0.150
Why?
Equipment Failure Analysis
1
2015
65
0.150
Why?
Elastic Modulus
1
2015
36
0.150
Why?
Furosemide
3
2011
18
0.150
Why?
Prosthesis Failure
1
2015
51
0.150
Why?
Materials Testing
1
2015
75
0.140
Why?
Education, Medical, Graduate
1
2017
231
0.140
Why?
Stress, Mechanical
1
2015
122
0.140
Why?
Prosthesis Design
1
2015
148
0.140
Why?
Asthma
1
1998
366
0.140
Why?
Drug Hypersensitivity
1
1994
22
0.140
Why?
Hepatitis
1
1994
44
0.130
Why?
Anticoagulants
2
2015
384
0.130
Why?
Receptors, Calcium-Sensing
1
2013
6
0.130
Why?
Hyperoxaluria
1
2013
5
0.130
Why?
Kidney Calculi
1
2013
16
0.130
Why?
Aged
13
2017
10747
0.130
Why?
Infant
1
2017
1314
0.130
Why?
Injections, Intradermal
1
2012
5
0.130
Why?
Dipyridamole
2
2011
22
0.130
Why?
Treatment Refusal
2
2007
59
0.130
Why?
Risk Assessment
2
2017
1569
0.130
Why?
Acetylcysteine
1
2012
19
0.130
Why?
Immunity, Cellular
1
1994
187
0.120
Why?
Patient Readmission
1
2017
349
0.120
Why?
Immunization, Secondary
1
2012
51
0.120
Why?
Retrospective Studies
6
2017
4302
0.120
Why?
Child, Preschool
1
2017
1637
0.120
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2008
123
0.120
Why?
Cardio-Renal Syndrome
1
2011
3
0.120
Why?
Nephrolithiasis
1
2011
8
0.120
Why?
Pregnancy Complications
1
1997
376
0.120
Why?
Ultrafiltration
1
2011
8
0.120
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2011
9
0.120
Why?
Serum Albumin
1
1992
39
0.120
Why?
Kidney Papillary Necrosis
1
1991
2
0.120
Why?
Follow-Up Studies
6
2017
1919
0.120
Why?
Contrast Media
2
2012
286
0.110
Why?
Infusions, Intravenous
1
2011
160
0.110
Why?
Plasma Exchange
1
2011
19
0.110
Why?
Myocardial Ischemia
1
2011
95
0.110
Why?
Infant, Low Birth Weight
2
1994
53
0.110
Why?
Acute Disease
5
2017
611
0.110
Why?
Immunohistochemistry
2
2013
817
0.110
Why?
Alcoholism
1
1993
257
0.110
Why?
Prospective Studies
4
2013
2449
0.110
Why?
Antibiotic Prophylaxis
1
2010
42
0.100
Why?
Metabolic Syndrome
1
2011
150
0.100
Why?
Glucocorticoids
1
2011
131
0.100
Why?
Parenteral Nutrition, Total
1
1989
23
0.100
Why?
Double-Blind Method
4
2009
550
0.100
Why?
Drug Resistance, Bacterial
1
2010
75
0.100
Why?
Anaphylaxis
2
2012
37
0.100
Why?
Adipose Tissue
1
2012
282
0.100
Why?
Drug Therapy, Combination
4
2011
365
0.100
Why?
Energy Metabolism
1
2012
331
0.100
Why?
Adolescent
4
2011
5237
0.100
Why?
Gene Expression Regulation, Developmental
1
2013
592
0.100
Why?
Hyaluronan Receptors
1
2009
34
0.100
Why?
Calcium
3
2007
528
0.100
Why?
Peritoneal Dialysis, Continuous Ambulatory
3
1997
4
0.090
Why?
Incidence
3
2017
1111
0.090
Why?
Angiotensin II Type 1 Receptor Blockers
1
2008
24
0.090
Why?
Diabetic Nephropathies
2
2005
28
0.090
Why?
Tetrazoles
2
2005
12
0.090
Why?
Aldosterone
2
1998
13
0.090
Why?
Length of Stay
1
2011
614
0.090
Why?
Biphenyl Compounds
2
2005
18
0.090
Why?
Clinical Laboratory Techniques
1
2008
50
0.090
Why?
Term Birth
1
2007
9
0.090
Why?
Early Diagnosis
1
2008
70
0.090
Why?
Ticlopidine
1
2008
60
0.090
Why?
Aged, 80 and over
3
2008
4196
0.090
Why?
Renal Insufficiency
2
2005
46
0.090
Why?
Urban Population
1
2008
185
0.080
Why?
Nephrocalcinosis
3
2007
5
0.080
Why?
Hemostatic Techniques
1
2006
7
0.080
Why?
Surgical Instruments
1
2006
31
0.080
Why?
Acecainide
1
1986
1
0.080
Why?
Hemoperfusion
1
1986
1
0.080
Why?
Procainamide
1
1986
5
0.080
Why?
Waldenstrom Macroglobulinemia
1
1986
9
0.080
Why?
Hyponatremia
1
1986
10
0.080
Why?
Ultrasonography, Doppler, Duplex
1
2006
49
0.080
Why?
Peritonitis
2
1997
29
0.080
Why?
Academic Medical Centers
1
2008
256
0.080
Why?
Ultrasonography, Interventional
1
2006
64
0.080
Why?
Bronchial Spasm
1
1985
6
0.080
Why?
Metals, Heavy
1
2005
7
0.080
Why?
Lactates
1
1985
26
0.080
Why?
Lithium
1
2005
16
0.080
Why?
Urologic Diseases
1
2005
10
0.080
Why?
Massachusetts
2
2010
1992
0.080
Why?
Cardiac Catheterization
1
2006
157
0.080
Why?
Proteins
1
1992
696
0.080
Why?
Lipids
1
1988
292
0.070
Why?
Diagnostic Imaging
1
2008
197
0.070
Why?
Iothalamic Acid
3
2000
3
0.070
Why?
Urinalysis
2
2007
29
0.070
Why?
Magnesium
1
1985
44
0.070
Why?
Analgesics
1
2005
93
0.070
Why?
Logistic Models
1
2008
1161
0.070
Why?
Prostaglandin-Endoperoxide Synthases
1
2004
24
0.070
Why?
Cyclooxygenase 2 Inhibitors
1
2004
23
0.070
Why?
Cyclooxygenase 2
1
2004
58
0.070
Why?
Hydrogen-Ion Concentration
2
2011
405
0.070
Why?
Isoenzymes
1
2004
124
0.070
Why?
Cardioplegic Solutions
1
2003
10
0.070
Why?
Heart Arrest, Induced
1
2003
9
0.070
Why?
Cardiopulmonary Bypass
1
2003
39
0.060
Why?
Intraoperative Care
1
2003
40
0.060
Why?
Antihypertensive Agents
1
2004
147
0.060
Why?
Obesity
1
2011
1106
0.060
Why?
Homeostasis
1
1985
306
0.060
Why?
Cyclosporine
2
2000
47
0.060
Why?
Infant, Newborn
5
2007
1091
0.060
Why?
Equipment Design
3
2010
271
0.060
Why?
Multiple Myeloma
1
2005
212
0.060
Why?
Program Evaluation
2
2017
449
0.060
Why?
Adenine Phosphoribosyltransferase
1
2001
1
0.060
Why?
Metabolism, Inborn Errors
1
2001
19
0.060
Why?
Cytokines
1
2004
859
0.050
Why?
Tissue and Organ Procurement
1
2000
31
0.050
Why?
Postoperative Period
1
2000
103
0.050
Why?
Cadaver
1
2000
92
0.050
Why?
Graft Rejection
1
2000
197
0.050
Why?
Bicarbonates
1
1998
13
0.050
Why?
Electrocardiography, Ambulatory
1
1998
20
0.050
Why?
Biopsy
1
2000
320
0.050
Why?
Forced Expiratory Volume
1
1998
56
0.050
Why?
United States
3
2017
6011
0.050
Why?
Diabetes Mellitus, Type 2
1
2005
586
0.050
Why?
Aerosols
1
1998
37
0.050
Why?
Administration, Inhalation
1
1998
78
0.050
Why?
Proportional Hazards Models
2
2011
632
0.050
Why?
Cross-Over Studies
1
1998
126
0.050
Why?
Membrane Proteins
1
2004
773
0.040
Why?
Glucose
2
2012
381
0.040
Why?
Graft Survival
1
1999
247
0.040
Why?
Renin
1
1997
9
0.040
Why?
Nontuberculous Mycobacteria
1
1997
4
0.040
Why?
Mycobacterium Infections, Nontuberculous
1
1997
8
0.040
Why?
Kidney Function Tests
1
2017
26
0.040
Why?
Infant, Very Low Birth Weight
1
1997
24
0.040
Why?
Injections, Intravenous
1
1997
140
0.040
Why?
Drug Resistance, Multiple
1
1997
28
0.040
Why?
Arteriovenous Fistula
2
2006
10
0.040
Why?
Infant, Premature, Diseases
1
1997
43
0.040
Why?
Hernia, Diaphragmatic
1
1996
2
0.040
Why?
Amino Acids
2
1989
130
0.040
Why?
Echocardiography
1
1998
307
0.040
Why?
African Americans
1
2000
532
0.040
Why?
Chronic Disease
3
2011
678
0.040
Why?
Heart Rate
1
1997
257
0.040
Why?
Vancomycin
1
1995
20
0.040
Why?
Polycythemia
1
1995
4
0.040
Why?
Albuminuria
1
1995
17
0.040
Why?
Infant Food
1
1994
4
0.040
Why?
Gram-Positive Bacterial Infections
1
1995
29
0.040
Why?
Survival Rate
1
2017
658
0.040
Why?
Ultrasonography
2
1999
375
0.040
Why?
Blood Glucose
1
1997
443
0.030
Why?
Acid-Base Equilibrium
1
1993
7
0.030
Why?
Acidosis, Lactic
1
1993
6
0.030
Why?
Ketosis
1
1993
3
0.030
Why?
Osmolar Concentration
1
1993
86
0.030
Why?
Gestational Age
2
2009
168
0.030
Why?
Immunophenotyping
1
1994
202
0.030
Why?
Recurrence
3
2001
490
0.030
Why?
Breast Feeding
1
1994
109
0.030
Why?
Insulin
1
1997
656
0.030
Why?
Administration, Intravenous
1
2012
47
0.030
Why?
Basal Metabolism
1
2012
25
0.030
Why?
Blood Pressure
2
2005
474
0.030
Why?
Urea
1
1992
31
0.030
Why?
Tomography, X-Ray
1
1991
4
0.030
Why?
Kidney Medulla
1
1991
7
0.030
Why?
Urography
1
1991
11
0.030
Why?
Body Composition
1
2012
171
0.030
Why?
Aspirin, Dipyridamole Drug Combination
1
2011
3
0.030
Why?
Diagnosis, Differential
1
1993
763
0.030
Why?
Drug Combinations
1
2011
117
0.030
Why?
Energy Intake
1
2012
228
0.030
Why?
Lymphocyte Activation
1
1994
761
0.030
Why?
Pregnancy
1
1997
1951
0.030
Why?
Endocarditis, Bacterial
1
2010
26
0.030
Why?
Parenteral Nutrition Solutions
1
1989
6
0.030
Why?
Tomography, X-Ray Computed
1
1996
1057
0.030
Why?
Shock, Septic
1
2010
62
0.030
Why?
Solutions
1
1989
60
0.030
Why?
Chi-Square Distribution
1
2010
399
0.020
Why?
Nephrons
1
2009
4
0.020
Why?
Kidney Tubules
1
2009
12
0.020
Why?
Ureter
1
2009
19
0.020
Why?
Postoperative Complications
2
2006
876
0.020
Why?
Epithelium
1
2009
100
0.020
Why?
Delayed-Action Preparations
1
2009
98
0.020
Why?
Practice Guidelines as Topic
1
2012
592
0.020
Why?
Organogenesis
1
2009
36
0.020
Why?
Kidney Tubular Necrosis, Acute
1
1988
2
0.020
Why?
Uremia
1
1988
10
0.020
Why?
Morphogenesis
1
2009
113
0.020
Why?
Kaplan-Meier Estimate
1
2009
352
0.020
Why?
Ambulatory Care
1
2010
268
0.020
Why?
Body Mass Index
1
2012
863
0.020
Why?
Renal Veins
1
1987
7
0.020
Why?
Lipoma
1
1987
16
0.020
Why?
Renal Artery
1
1987
28
0.020
Why?
Biomarkers
1
2011
949
0.020
Why?
Hemangioma
1
1987
23
0.020
Why?
Equipment Safety
1
2006
16
0.020
Why?
Alloys
1
2006
27
0.020
Why?
Collateral Circulation
1
2006
18
0.020
Why?
Femoral Vein
1
2006
18
0.020
Why?
Diuresis
1
1986
7
0.020
Why?
Aneurysm, False
1
2006
36
0.020
Why?
Hemostasis
1
2006
31
0.020
Why?
Arginine Vasopressin
1
1986
23
0.020
Why?
Water-Electrolyte Balance
1
1986
18
0.020
Why?
Arterial Occlusive Diseases
1
2006
58
0.020
Why?
Hematoma
1
2006
54
0.020
Why?
Femoral Artery
1
2006
73
0.020
Why?
Saphenous Vein
1
2006
52
0.020
Why?
Venous Thrombosis
1
2006
101
0.020
Why?
Amlodipine
1
2005
2
0.020
Why?
Fanconi Syndrome
1
1985
1
0.020
Why?
Glycosuria
1
1985
4
0.020
Why?
Natriuresis
1
1985
5
0.020
Why?
Edetic Acid
1
1984
18
0.020
Why?
Lead Poisoning
1
1984
7
0.020
Why?
Physical Exertion
1
1985
73
0.020
Why?
Kidney Neoplasms
1
1987
165
0.020
Why?
Microscopy, Electron
1
1985
247
0.020
Why?
Hypoxia
1
1985
74
0.020
Why?
Kinetics
1
1986
725
0.020
Why?
Plasma Substitutes
1
2003
7
0.020
Why?
Myocardial Reperfusion Injury
1
2003
25
0.020
Why?
Isotonic Solutions
1
2003
18
0.020
Why?
Oxygen
1
1985
234
0.020
Why?
Intraoperative Complications
1
2003
57
0.020
Why?
Reproducibility of Results
1
2006
1315
0.020
Why?
Predictive Value of Tests
1
2004
834
0.010
Why?
Antimetabolites
1
2001
15
0.010
Why?
Heart Diseases
1
2003
163
0.010
Why?
Muromonab-CD3
1
2000
9
0.010
Why?
Azathioprine
1
2000
22
0.010
Why?
Hypertension
1
2005
524
0.010
Why?
Evaluation Studies as Topic
1
1999
110
0.010
Why?
Transplantation, Homologous
1
2000
193
0.010
Why?
Observer Variation
1
1999
174
0.010
Why?
Metabolic Clearance Rate
1
1999
38
0.010
Why?
Creatine
1
1999
18
0.010
Why?
Adrenal Cortex Hormones
1
2000
93
0.010
Why?
Sodium
1
1997
51
0.010
Why?
Dose-Response Relationship, Drug
1
1999
759
0.010
Why?
Ethics, Medical
1
1996
28
0.010
Why?
Microbial Sensitivity Tests
1
1997
150
0.010
Why?
Analysis of Variance
1
1997
554
0.010
Why?
Iodine Radioisotopes
1
1995
52
0.010
Why?
Calcium Phosphates
1
1994
8
0.010
Why?
Erythropoietin
1
1995
30
0.010
Why?
Family
1
1996
190
0.010
Why?
Decision Making
1
1996
311
0.010
Why?
Mental Disorders
1
1996
636
0.010
Why?
Hematuria
1
1987
18
0.010
Why?
Radiography
1
1987
337
0.000
Why?
Acetic Acid
1
1985
9
0.000
Why?
Acetates
1
1985
26
0.000
Why?
Pulmonary Gas Exchange
1
1985
35
0.000
Why?
Carbon Dioxide
1
1985
64
0.000
Why?
Occupational Diseases
1
1984
252
0.000
Why?
Braden's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (372)
Explore
_
Co-Authors (17)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_